Aarti Pharmalabs Limited (NSE:AARTIPHARM)

Market Cap	67.31B
Revenue (ttm)	19.06B
Net Income (ttm)	2.40B
Shares Out	90.65M
EPS (ttm)	26.44
PE Ratio	28.08
Forward PE	n/a
Dividend	5.00 (0.67%)
Ex-Dividend Date	Sep 15, 2025

Volume	35,327
Average Volume	160,910
Open	742.50
Previous Close	742.50
Day's Range	731.45 - 742.75
52-Week Range	568.10 - 971.00
Beta	-0.36
RSI	49.28
Earnings Date	Nov 9, 2025

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 2,162
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AARTIPHARM

Financial Performance

In 2024, Aarti Pharmalabs's revenue was 21.15 billion, an increase of 14.17% compared to the previous year's 18.53 billion. Earnings were 2.72 billion, an increase of 25.59%.